We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
The test demonstrated 94 percent sensitivity in detecting clinically significant prostate cancer in a recent validation study, the company said. Read More
Abbott has received FDA’s approval of its new Proclaim Plus spinal cord stimulation (SCS) system that allows physicians to program the device to treat evolving pain. Read More
Viseon plans to launch the MaxView System later this year, enabling users to record clinical procedures in HD resolution for use in teaching. Read More
The Pascal system is one of multiple transcatheter repair or replacement systems the company is developing to address mitral and tricuspid valve diseases. Read More